Breo Ellipta (Fluticasone Furoate & Vilanterol Trifenatate)

Breo Ellipta (Fluticasone Furoate & Vilanterol Trifenatate)


Click if you found lower price?


Add to cart
Buy Now

Product Details


BREO ELLIPTA (Umeclidinium) is a prescription that contains a combination of medications and is prescribed to treat asthma and chronic obstructive pulmonary disease (COPD). Asthma and COPD are diseases of the lungs that make it difficult for a person to breathe. BREO ELLIPTA is a daily medication that helps to reduce some of the symptoms like shortness of breath, coughing, and wheezing.


The usual dosage is one inhalation once daily when using BREO ELLIPTA for cough and the reduction of other symptoms.

After inhalation, rinse the mouth with water and do not swallow. If the mouth is not rinsed after use, the risk of oropharyngeal candidiasis (oral thrush) may increase.

BREO ELLIPTA should be taken every day. It is not a rescue medication and should not be used for the relief of acute bronchospasm. In the case of acute symptoms like shortness of breath, an inhaled medication like albuterol should be used for relief instead of a maintenance inhaler like BREO ELLIPTA.

If used regularly, BREO ELLIPTA will reduce the severity of asthma and COPD symptoms and reduce the need for a rescue inhaler.


Fluticasone furoate

Fluticasone is an inhaled corticosteroid medication (ICS). Corticosteroids are signaling molecules that reduce inflammation. During bronchospasms, the airways of the lungs are often swollen and inflamed, and regular usage of an ICS decreases this.


Vilanterol is a long-acting beta2-agonist (LABA). Beta receptors are present on the surface of muscle cells in the lungs. By activating these receptors, vilanterol relaxes the muscles of the airway, making it easier to breathe.


The usage of BREO ELLIPTA may increase the risk of pneumonia and other bronchial infections in certain patients.

BREO ELLIPTA may rarely cause a paradoxical reaction where the airways spasm, making it harder to breathe. If this happens while taking BREO ELLIPTA, stop the medication and tell your physician.

BREO ELLIPTA should be used with caution in patients with a history of cardiovascular disorders.

BREO ELLIPTA should be used with caution in diabetic patients or those with a history of hypokalemia.

Speak with your physician for a full list of warnings and precautions.

Side Effects

Common adverse effects of BREO ELLIPTA include:

  • Arthralgia
  • Back pain
  • Bronchitis
  • Cough
  • Dysphonia
  • Headache
  • Hypertension
  • Influenza
  • Nasopharyngitis
  • Oral candidiasis
  • Oropharyngeal pain
  • Pharyngitis
  • Pneumonia
  • Pyrexia
  • Sinusitis
  • Upper respiratory tract infection